Imunon Inc. has announced a change in its financial management team, effective June 13, 2025. The company has terminated its agreement with Monomoy Advisors, LLC, ending David Gaiero's role as interim Chief Financial Officer. Kimberly Graper has been appointed as the interim Chief Financial Officer, taking on responsibilities as the principal financial officer and principal accounting officer. Graper joined Imunon Inc. in October 2022 as Vice President of Finance and Corporate Controller, bringing extensive experience from previous roles in the biotech and healthcare industries.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.